Selected research
Industry Research
H7N9 Vaccines Industry Research Report 2026
Market perspective
The global H7N9 Vaccines market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for H7N9 Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for H7N9 Vaccines is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for H7N9 Vaccines is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of H7N9 Vaccines include Hualan Bio, North Carolina Biotechnology, Beijing Tiantan Biological Products, Sinovac and Novavax, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global H7N9 Vaccines market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
H7N9 Vaccines Market by Company
Hualan Bio
North Carolina Biotechnology
Beijing Tiantan Biological Products
Sinovac
Novavax
H7N9 Vaccines Segment by Type
H7N9 Split Vaccine
H7N9 Live Attenuated Vaccine
Others
H7N9 Vaccines Segment by Application
Treatment
Research Institutions
H7N9 Vaccines Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global H7N9 Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of H7N9 Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of H7N9 Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of H7N9 Vaccines manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of H7N9 Vaccines by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of H7N9 Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- H7N9 Split Vaccine
- H7N9 Live Attenuated Vaccine
- Others
Applications
- Treatment
- Research Institutions
Companies covered
- Hualan Bio
- North Carolina Biotechnology
- Beijing Tiantan Biological Products
- Sinovac
- Novavax
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global H7N9 Vaccines Market Size (2021-2032)
- 2.2.2 Global H7N9 Vaccines Sales (2021-2032)
- 2.2.3 Global H7N9 Vaccines Market Average Price (2021-2032)
- 2.3 H7N9 Vaccines by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 H7N9 Split Vaccine
- 2.3.3 H7N9 Live Attenuated Vaccine
- 2.3.4 Others
- 2.4 H7N9 Vaccines by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Treatment
- 2.4.3 Research Institutions
3 Market Competitive Landscape by Manufacturers
- 3.1 Global H7N9 Vaccines Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global H7N9 Vaccines Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global H7N9 Vaccines Revenue of Manufacturers (2021-2026)
- 3.4 Global H7N9 Vaccines Average Price by Manufacturers (2021-2026)
- 3.5 Global H7N9 Vaccines Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of H7N9 Vaccines, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of H7N9 Vaccines, Product Type & Application
- 3.8 Global Manufacturers of H7N9 Vaccines, Established Date
- 3.9 Global H7N9 Vaccines Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Hualan Bio
- 4.1.1 Hualan Bio Company Information
- 4.1.2 Hualan Bio Business Overview
- 4.1.3 Hualan Bio H7N9 Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Hualan Bio H7N9 Vaccines Product Portfolio
- 4.1.5 Hualan Bio Recent Developments
- 4.2 North Carolina Biotechnology
- 4.2.1 North Carolina Biotechnology Company Information
- 4.2.2 North Carolina Biotechnology Business Overview
- 4.2.3 North Carolina Biotechnology H7N9 Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 North Carolina Biotechnology H7N9 Vaccines Product Portfolio
- 4.2.5 North Carolina Biotechnology Recent Developments
- 4.3 Beijing Tiantan Biological Products
- 4.3.1 Beijing Tiantan Biological Products Company Information
- 4.3.2 Beijing Tiantan Biological Products Business Overview
- 4.3.3 Beijing Tiantan Biological Products H7N9 Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Beijing Tiantan Biological Products H7N9 Vaccines Product Portfolio
- 4.3.5 Beijing Tiantan Biological Products Recent Developments
- 4.4 Sinovac
- 4.4.1 Sinovac Company Information
- 4.4.2 Sinovac Business Overview
- 4.4.3 Sinovac H7N9 Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Sinovac H7N9 Vaccines Product Portfolio
- 4.4.5 Sinovac Recent Developments
- 4.5 Novavax
- 4.5.1 Novavax Company Information
- 4.5.2 Novavax Business Overview
- 4.5.3 Novavax H7N9 Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Novavax H7N9 Vaccines Product Portfolio
- 4.5.5 Novavax Recent Developments
5 Global H7N9 Vaccines Market Scenario by Region
- 5.1 Global H7N9 Vaccines Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global H7N9 Vaccines Sales by Region: 2021-2032
- 5.2.1 Global H7N9 Vaccines Sales by Region: 2021-2026
- 5.2.2 Global H7N9 Vaccines Sales by Region: 2027-2032
- 5.3 Global H7N9 Vaccines Revenue by Region: 2021-2032
- 5.3.1 Global H7N9 Vaccines Revenue by Region: 2021-2026
- 5.3.2 Global H7N9 Vaccines Revenue by Region: 2027-2032
- 5.4 North America H7N9 Vaccines Market Facts & Figures by Country
- 5.4.1 North America H7N9 Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America H7N9 Vaccines Sales by Country (2021-2032)
- 5.4.3 North America H7N9 Vaccines Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe H7N9 Vaccines Market Facts & Figures by Country
- 5.5.1 Europe H7N9 Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe H7N9 Vaccines Sales by Country (2021-2032)
- 5.5.3 Europe H7N9 Vaccines Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific H7N9 Vaccines Market Facts & Figures by Country
- 5.6.1 Asia Pacific H7N9 Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific H7N9 Vaccines Sales by Country (2021-2032)
- 5.6.3 Asia Pacific H7N9 Vaccines Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America H7N9 Vaccines Market Facts & Figures by Country
- 5.7.1 South America H7N9 Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America H7N9 Vaccines Sales by Country (2021-2032)
- 5.7.3 South America H7N9 Vaccines Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.7.7 Colombia
- 5.8 Middle East and Africa H7N9 Vaccines Market Facts & Figures by Country
- 5.8.1 Middle East and Africa H7N9 Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa H7N9 Vaccines Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa H7N9 Vaccines Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global H7N9 Vaccines Sales by Type (2021-2032)
- 6.1.1 Global H7N9 Vaccines Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global H7N9 Vaccines Sales Market Share by Type (2021-2032)
- 6.2 Global H7N9 Vaccines Revenue by Type (2021-2032)
- 6.2.1 Global H7N9 Vaccines Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global H7N9 Vaccines Revenue Market Share by Type (2021-2032)
- 6.3 Global H7N9 Vaccines Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global H7N9 Vaccines Sales by Application (2021-2032)
- 7.1.1 Global H7N9 Vaccines Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global H7N9 Vaccines Sales Market Share by Application (2021-2032)
- 7.2 Global H7N9 Vaccines Revenue by Application (2021-2032)
- 7.2.1 Global H7N9 Vaccines Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global H7N9 Vaccines Revenue Market Share by Application (2021-2032)
- 7.3 Global H7N9 Vaccines Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 H7N9 Vaccines Value Chain Analysis
- 8.1.1 H7N9 Vaccines Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 H7N9 Vaccines Production Mode & Process
- 8.2 H7N9 Vaccines Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 H7N9 Vaccines Distributors
- 8.2.3 H7N9 Vaccines Customers
9 Global H7N9 Vaccines Analyzing Market Dynamics
- 9.1 H7N9 Vaccines Industry Trends
- 9.2 H7N9 Vaccines Industry Drivers
- 9.3 H7N9 Vaccines Industry Opportunities and Challenges
- 9.4 H7N9 Vaccines Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst